0

Finafloxacin

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP209342405
CAS209342-40-5
Structure
Molecular Weight398.39
Description≥95% (HPLC)
SolubilityDMSO: 2 mg/mL, clear (warmed)
Assay≥95% (HPLC)
Colorwhite to beige
Formpowder
Size10MG, 50MG
Storage Conditions−20°C
1

Developments on Antibiotics for Multidrug Resistant Bacterial Gram-negative Infections

Georgios L Voulgaris, Maria L Voulgari, Matthew E Falagas

Expert Rev Anti Infect Ther. 2019 Jun;17(6):387-401.

PMID: 31006284

1

Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin Versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections

F Wagenlehner, M Nowicki, C Bentley, M Lückermann, S Wohlert, C Fischer, A Vente, K Naber, A Dalhoff

Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02317-17.

PMID: 29339395

1

Fluoroquinolones Structural and Medicinal Developments (2013-2018): Where Are We Now?

Ghadeer A R Y Suaifan, Aya A M Mohammed

Bioorg Med Chem. 2019 Jul 15;27(14):3005-3060.

PMID: 31182257

1

Influence of pH on the Activity of Finafloxacin Against Extracellular and Intracellular Burkholderia Thailandensis, Yersinia Pseudotuberculosis and Francisella Philomiragia and on Its Cellular Pharmacokinetics in THP-1 Monocytes

H Chalhoub, S V Harding, P M Tulkens, F Van Bambeke

Clin Microbiol Infect. 2019 Aug 9;S1198-743X(19)30420-3.

PMID: 31404671

1

Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers

Max Taubert, Joseph Chiesa, Mark Lückermann, Carsten Fischer, Axel Dalhoff, Uwe Fuhr

Antimicrob Agents Chemother. 2017 Sep 22;61(10):e01122-17.

PMID: 28784673

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode